INTRODUCTION
============

Restriction--modification (R--M) systems encode a restriction endonuclease and a DNA methyltransferase (methylase). The methylase protects the bacterial host DNA from cleavage by the associated endonuclease by methylation of the cognate DNA recognition sequence. Bacterial cells carrying R--M genes become resistant to infection by bacteriophages with unmethylated (unmodified) DNA and thus gain a selective advantage over bacteria of the same species but lacking R--M genes. Thus, R--M genes frequently spread through horizontal transfer on broad host range plasmids ([@B1],[@B2]). R--M systems can also be considered as 'addictive' modules that are impossible to eliminate because the protective methylase is less stable than the toxic restriction endonuclease ([@B2],[@B3]). Plasmids containing R--M systems can be readily transformed into cells containing unmodified DNA, suggesting that sufficient amounts of methylase are produced to completely methylate host DNA before the endonuclease activity appears. Thus, R--M systems must have evolved mechanisms of coordinate expression of their genes to minimize potentially fatal consequences to the host bacterium.

Many type II R--M systems rely on specialized Controller (C) proteins for coordinated expression of their genes ([@B4; @B5; @B6; @B7; @B8; @B9; @B10]). All C-proteins are related through common ancestry and contain a DNA binding helix--turn--helix motif ([@B11]). The structures of two C-proteins that have been studied by crystallography revealed that these proteins form dimers and that each monomer is similar to the DNA-binding domain of the λ repressor ([@B12],[@B13]), although there are important differences at the dimer interface that determine the strength of dimerization, which is crucial to the timing of the genetic switch ([@B14],[@B15]).

Genes coding for C-proteins are almost invariably located upstream of, and partially overlap with the endonuclease gene ([@B7; @B8; @B9]), forming a single operon. Two C-protein binding sites are located upstream of and partially overlapping with the *CR* operon promoter ([@B16]). When a C-protein dimer binds to the high-affinity promoter--distal site, transcription is activated leading to increased C-protein and endonuclease gene expression. Binding to the weaker promoter--proximal site inhibits transcription ([@B7],[@B14],[@B17]). C-proteins were also shown to inhibit expression of methylases in some R--M systems ([@B8],[@B18]).

The regulation of R--M gene expression depends on the relative positions of genes in the system. In C-protein-dependent R--M systems with divergent organization of CR and M genes, such as the EcoRV system, interaction of the C-protein with the high-affinity distal (with respect to CR promoter) site decreases transcription from the M promoter due to direct interference from the bound C-protein ([@B7]). In the C-protein-dependent R--M system AhdI, the M and the CR operons are transcribed convergently ([@B14],[@B17]). The *ahdI* CR operon expression is regulated by C-protein in a manner generally analogous to that observed in the case of EcoRV CR operon regulation. However, M gene expression is C-protein-independent and is instead regulated by the *Ahd* I methylase, which methylates an AhdI site embedded in the −10 element of the M promoter leading to decreased transcription ([@B17]).

The object of this study, C-protein-dependent R--M system Esp1396I, contains convergent M and CR genes but with no Esp1396I restriction sites in front of the M gene. Nevertheless, *in vivo* analysis revealed that *esp1396IM* expression is inhibited by C.Esp1396I ([@B8]). Sequence analysis suggested the presence of tetranucleotide inverted repeats in front of the *esp1396ICR* operon (two sets of repeats) and the *esp1396IM* gene (one set of perfect repeats and another putative set that contained several substitutions) ([@B9]). The repeats matched well with C-protein binding sites from several other C-protein-dependent R--M systems and very recently the *esp1396ICR* operon repeats were shown to indeed interact with C.Esp1396I ([@B19]). However, the overall role of C.Esp1396I binding sites locations in differential regulation of the *esp1396ICR* operon and *esp1396IM* gene expression has not yet been investigated. Moreover, the result of the structural analysis suggests that elements of the binding site distinct from tetranucleotide repeat *per se* contribute significantly to C.Esp1396I binding. These elements, such as a conserved TATA spacer between the repeats and inverted dinucleotides flanking the site upstream of the *esp1396ICR* operon, are missing in one of the putative binding sites upstream of *esp1396IM*, raising a question about its significance. Here, we determine transcription initiation start points of both *esp1396I* transcription units, show that there is only one C-protein binding site in front of *esp1396IM*, analyze C.Esp1396I interactions with DNA operator sequences, discuss the regulatory consequences of these interactions *in vivo* and *in vitro*, and derive a plausible scenario of transcription regulation of the *esp1396I* genes. In addition, we test the importance of the elements of protein--DNA recognition indicated by the crystal structure of the complex ([@B19]).

MATERIALS AND METHODS
=====================

Bacteria strains, phages and media
----------------------------------

*Escherichia coli* HB101 and XL1-Blue were used as host strains in experiments to study the *esp1396I* genes expression and λvir phage resistance. Phage λvir was propagated as described ([@B20]). Cells were grown in LB medium (1% bactotryptone, 1% NaCl, 0.5% yeast extract, with or without 1.5% bactoagar) supplemented with appropriate antibiotics. To test for *esp1396I* genes expression *in vivo*, McConkey agar base plates containing 1% galactose were used.

Plasmids and proteins
---------------------

Plasmid pEsp1396IRM5.6 ([@B8]) carrying the entire Esp1396I R--M system was used as a template for PCR amplification of DNA fragments used for cloning, mutagenesis and *in vitro* transcription. Plasmids pEspMet and pEspRes are derivatives of the pFD51 plasmid ([@B21]) with the galactokinase gene (*galK*) under the control of the *esp1396IM* and *esp1396ICR* promoters, respectively. Plasmid pEspMet contains a 101-bp PCR-amplified *esp1396IM* fragment (−74 to +27 with respect to the transcription start point at +1); pEspRes contains a 103-bp *esp1396IR* fragment (−70 to +33 with respect to the transcription start). Plasmid pCesp184 was created by cloning a 347-bp PCR fragment containing the *esp1396IC* gene and the *esp1396ICR* promoter between the NcoI and EcoRI sites of plasmid pACYC184.

Hexahistidine-tagged C.Esp1396I (C.Esp1396I-6His) and C.Esp1396I without hexahistidine tag were purified as described ([@B19]). The protein concentration was determined using the Bradford method with BSA as a standard. For analytical ultracentrifugation experiments, UV absorption spectroscopy was used to measure the protein concentration, taking the theoretical extinction coefficient *ε*~276~ = 2900 M^−1^ cm^−1^. Throughout the text, molar concentration of C.Esp1396I refers to monomer concentration.

*Escherichia coli* RNAP σ^70^ holoenzyme was purified as described ([@B22]).

Primer extension reactions
--------------------------

HB101 cells harboring the pEspMet and pEspRes plasmids with or without compatible pCesp184 plasmid were grown to OD~600~ = 0.4 and total RNA was extracted using RNeasy Mini Kit (Qiagen) according to the manufacturer\'s protocol with the inclusion of the DNaseI digestion step. For a single extension reaction, 10 μg of total RNA were reverse-transcribed with 100 U of SuperScript III enzyme of First-Strand Synthesis Kit for RT--PCR (Invitrogen) according to the manufacturer\'s protocol in the presence of 1 pmol of \[^32^P\] 5′-end-labeled primers. The reaction products were treated with RNase H, precipitated by ethanol and dissolved in a loading buffer containing 7 M urea--formamide and resolved on 6% sequencing gels. Sequencing reactions performed with the same end-labeled primers and pEspMet and pEspRes as a templates using *fmol* DNA Cycle Sequencing System (Promega).

Electrophoretic mobility shift assay
------------------------------------

A 10 nM \[^32^P\]-end-labeled DNA fragments containing the wild-type or mutant C-protein-binding sites were incubated for 10 min at 37°C in 10 µl reaction buffer \[40 mM Tris--HCl (pH 8.0) 10 mM NaCl, 10 mM MgCl~2~, 1 mM DTT, 5% glycerol\] with 0--1024 nM of C.Esp1396I-6His in the presence of 5 µg/ml of competitor DNA. Following the addition of 2 µl of loading buffer (30% glycerol, 0.05% bromophenol blue, 10 mM EDTA), samples were loaded onto 8% native polyacrylamide gels. After electrophoresis, reaction products were visualized and quantified using a PhosphorImager.

Footprinting and *in vitro* transcription
-----------------------------------------

For *in vitro* transcription, promoter complexes were allowed to form for 10 min at 37°C in 10 µl reactions containing 40 mM Tris--HCl (pH 8.0) 40 mM KCl, 10 mM MgCl~2~, 1 mM DTT, 5% glycerol, 100 nM *E. coli* RNAP σ^70^ holoenzyme and 10 nM *esp1396I* DNA fragments. Where indicated, DNA was incubated with C.Esp1396I-6His prior to the addition of RNAP. To initiate transcription reaction, a mixture of 200 μM ATP, CTP and UTP, 20 μM GTP and 10 μCi of \[α-^32^P\]GTP (3000 Ci/mmol) and heparin (final concentration 30 μg/ml) was added to promoter complexes. After incubation at 37°C for 15 min, reactions were terminated by the addition of equal volume of 7 M urea--formamide-containing loading buffer and resolved on 8% sequencing gels.

KMnO~4~ probing and DNase I footprinting were conducted under conditions used for *in vitro* transcription using P^32^-labeled promoter fragments as described ([@B17]). G+A sequencing reactions were carried out as described ([@B23]). Samples were applied on 6% sequencing gels and reaction products revealed using a PhosphorImager.

Sedimentation velocity and sedimentation equilibrium experiments
----------------------------------------------------------------

Sedimentation velocity experiments were performed in a Beckman XL-A analytical ultracentrifuge equipped with an An50-Ti rotor using double sector cells of 12 mm optical path-length. Sample cells contained 400 μl of C.Esp1396I at 0, 10 and 20 μM and Hex-labeled 35-bp DNA fragments containing the binding sites (5 μM). The reference cells contained 425 μl of buffer (40 mM Tris--HCl pH 8.0, 100 mM NaCl and 5% glycerol). The cells were loaded and left to equilibrate to 20°C. The rotor was accelerated to 40 000 r.p.m. and readings of absorbance versus radial distance were taken every 12 min at 540 nm. The raw data were analyzed with program Sedfit ([@B24]), using radial data within the range 6.07--6.93 cm for the first 75 scans. Partial specific volumes for the dimer and tetramer (0.644 and 0.678 ml/g, respectively) were calculated using the program Sednterp and corrected for temperature ([@B25]). For DNA alone, a value of 0.55 ml/g was used corresponding to tabulated values ([@B26]); for dimer and tetramer nucleoprotein complexes, weight average values were calculated. Finally, the experimental sedimentation coefficients obtained from the c(S) distribution plot were corrected for temperature and solvent to obtain a s~20,w~ value.

Sedimentation equilibrium experiments were performed using the same centrifuge and rotor as for the velocity experiments. Six-channel cells of 12 mm optical path-length containing 90 µl of solution at protein concentrations ranging from 5 to 64 µM were used; 100 µl of the sample buffer (40 mM Tris--HCl, pH 8.0, 100 mM NaCl, 5% glycerol) was loaded into the corresponding channel. The rotor was accelerated to 15 000, 21 000 and 28 000 r.p.m. and scans of absorbance (275 and 235 nm) versus radial displacement were taken at a resolution of 0.001 cm for times up to 21 h. The temperature was set at 20°C.

Fluorescence polarization assays
--------------------------------

HPLC-purified fluorescein-labeled oligonucleotides and their complementary partners were obtained from ITD (Corralville, IA, USA). The 20 μl reaction mixtures (in 40 mM Tris--HCl, pH 8.0, 10 mM MgCl~2~, 5% glycerol and 50 μg/ml calf thymus DNA) containing 10 nM fluorescein-labeled DNA and indicated C.Esp1396I protein concentration were prepared in triplicates and fluorescence polarization was read in 384-well microplates using Analyst AD reader (Molecular Devices, Sunnyvale, CA, USA).

Fluorescence polarization data were analyzed using numerical nonlinear regression with SCIENTIST (MicroMath, Salt Lake City, UT, USA). Equilibrium titrations of P*esp1396IM* DNA with C.Esp1396I were fitted to: where, pol is observed fluorescence polarization, pol~1~ and pol~2~ are specific fluorescence polarizations of free DNA and DNA in complex with the C.Esp1396I protein dimer (P), respectively. Binding of C.Esp1396I to the Pe*sp1396IM* DNA is described by two equilibrium constants: protein dimerization constant (*K*~dim~; it was fixed at 600 nM during fitting, the value measured by analytical centrifugation) and dissociation constant of protein dimer--DNA complex (*K*). Equilibrium titrations of P*esp1396ICR* DNA with the protein were fitted to: where, pol is observed fluorescence polarization, pol~1~, pol~2~ and pol~3~ are specific fluorescence polarizations of free DNA, DNA in complex with one C.Esp1396I dimer, and DNA in complex with two C.Esp1396I dimers, respectively. P:DNA~p~ and P:DNA~d~ refer to of C.Esp1396I dimers bound to the proximal and distal site, respectively. Binding of C.Esp1396I to the P*esp1396ICR* DNA is described by four parameters: protein dimerization constant (*K*~dim~; fixed at 600 nM during fitting, the value measured by analytical centrifugation), dissociation constants of C.Esp1396I dimer complexes with proximal and distal sites (*K*~p~ and *K*~d~, respectively) and a cooperatively constant describing the effect of C.Esp1396I binding to one site on the affinity of the protein to the other site (calculated as the ratio of equilibrium constants for a given site when the other site is bound and free, respectively). During the fit, concentrations of all species were calculated numerically for each point by solving the appropriate set of mass conservation equations defined by a particular model ([@B27]). The data for the wild-type and all of the mutant DNA fragments were fitted simultaneously to force common parameters between data sets to be the same.

RESULTS
=======

Mapping transcription start sites in Esp1396I
---------------------------------------------

The genetic organization of Esp1396I is shown in [Figure 1](#F1){ref-type="fig"}. The *esp1396IC* and *esp1396IR* genes partially overlap and likely form an operon. The *esp1396IM* gene is transcribed convergently with respect to the *esp1396ICR* gene pair. A putative bidirectional transcription terminators is located in the intergenic region separating the *esp1396ICR* genes and the *esp1396IM* gene. Figure 1.Genetic organization of restriction--modification system Esp1396I. The *esp1396I* genes with upstream C.Esp1396I binding sites are schematically shown on the top. Arrows show the direction of transcription. Two *esp1396I* transcription units (M and CR) are separated by a region that may contain a bidirectional transcription terminator (depicted as a hairpin). DNA sequences around transcription start points of the *esp1396IM* and *esp1396ICR* promoters are expanded below (both DNA strands are shown). Beginnings of coding regions are indicated with colors that match those at the top of the figure and *esp1396IC* and *esp1396IM* are highlighted in bold typeface and indicated as 'Met^1'^. The P*esp1396IM* and P*esp1396ICR* start sites are indicated by red color and bold typeface, and leftward and rightward arrows below and above the sequence. Conserved promoter elements are labeled and underlined. The *esp1396ICR* C-box is indicated by blue color and a black line above the sequence with distal and proximal C.Esp1396I binding sites labeled. Two sets of inverted repeats are shown by convergent arrows. Sequences constituting the recently discovered 'TATA'-based dyad are boxed. Sequences within one set of perfect inverted repeats in P*esp1396IM* are similarly indicated and highlighted with orange-colored font. An imperfect set of repeats in P*esp1396IM* identified in ref. ([@B8]) is shown by inverted arrows above black-colored font. At the top of the figure, the orientation of C.Esp1396I dimers at promoter-distal (subunits A, B) and promoter-proximal (subunits C, D) P*esp1396ICR* binding sites is shown ([@B19]).

To better understand the regulation of Esp1396I, we identified transcription start points of Esp1396I genes by performing primer extension reactions with total RNA prepared from *E. coli* cells harboring a plasmid containing complete Esp1396I R--M system ([@B8]). This plasmid is stably maintained in *E. coli* and cells harboring this plasmid restrict the growth of phage λ ([Figure 2](#F2){ref-type="fig"}A, left panel) indicating that both Esp1396I methyltransferase and restriction endonuclease are expressed. We wished to use RNA from cells harboring an Esp1396I R--M plasmid containing a lesion in the *esp1396IC* gene to reveal C.Esp1396I-dependent transcription start sites. However, no such plasmid could be constructed, indicating that intact *esp1396IC* is necessary for establishment and/or maintenance of *esp1396*I genes in the cell. Similar observations were made previously and were explained by postulating that expression of the *esp1396IM* gene in the absence of C.Esp1396I is toxic to the cell ([@B8]). Extension of primers annealing to various places within the *esp1396ICR* genes revealed a single primer extension product ([Figure 2](#F2){ref-type="fig"}A, center panel and data not shown), supporting the notion that the *esp1396ICR* gene pair is transcribed from a single promoter ([@B8]). The primer extension product mapped to an adenine located 27-bp upstream of the initiating ATG codon of *esp1396IC*. Thus, unlike several other studied *CR* transcripts that were shown to be leaderless ([@B7; @B17; @B28]), the *esp1396ICR* transcript is translated in a conventional way (indeed, there is a recognizable Shine--Dalgarno sequence at an appropriate distance from the initiating ATG codon of *esp1396*I.C, [Figure 1](#F1){ref-type="fig"}). The *esp1396ICR* transcription start site is preceded by a CATTAT sequence that is appropriately positioned to serve as a −10 promoter element (consensus sequence TATAAT). The place where the −35 promoter element (consensus sequence TTGACA) should be located contains a GTGTGA sequence. Thus, the similarity of the *esp1396ICR* promoter (P*esp1396ICR*) elements to consensus elements is low, suggesting that basal activity level of this promoter is also low. Primer extension reactions with a primer designed to reveal transcription from the *Esp1396*I methylase promoter (P*esp1396IM*) revealed a single product whose 5′-end corresponded to a thymidine located 20-bp upstream of the initiating ATG of *esp1396IM* ([Figure 2](#F2){ref-type="fig"}A, right panel). This residue is preceded by an appropriately positioned TAGAAT sequence that is highly similar to the consensus −10 promoter element sequence TATAAT; at an appropriate distance upstream, a TTGAAA sequence that is similar to the −35 promoter consensus element sequence TTGACA is located ([Figure 1](#F1){ref-type="fig"}). Figure 2.Expression of the *esp1396I* genes *in vivo*. (**A**) The horizontal lines on the left panel show overnight 37°C growth of *E. coli* cells harboring a plasmid containing the entire Esp1396I system of without such a plasmid on an LB agar plate. Cells were spotted with indicated dilutions of λ-*vir* phage lysate. Two panels on the right show the results of primer extension analysis carried out with RNA purified from cells harboring a plasmid containing the entire Esp1396I system with a primer specific for *esp1396ICR* transcription unit (middle panel) or with a *esp1396IM*-specific primer (right panel). Primer extension products are indicated by arrows. (**B** and **C**) Top panels shows the results of overnight 37°C growth of *E. coli* cells harboring *esp1396ICR* (B) or *esp1396IM* (C) promoters fused to promotorless *galK* in the absence ([@B1]) or presence ([@B2]) or a compatible plasmid expressing C.Esp1396I on McConkey agar plates. Bottom panels show the results of primer extension analysis of RNA purified from cells shown at the top with a *galK* specific primer.

To show C.Esp1396I-dependence of *esp1396I* promoters, fragments containing P*esp1396ICR* or P*esp1396IM* with corresponding flanking sequences were cloned in front of promoterless *gal*K gene of the pFD51 plasmid. Cells containing the resultant P*esp1396ICR*::*galK* fusion plasmid pEspRes formed white colonies on McConkey agar ([Figure 2](#F2){ref-type="fig"}B, top, plate sector 1) and no primer extension product corresponding to P*esp1396ICR* transcript could be detected ([Figure 2](#F2){ref-type="fig"}B, bottom, lane 1). However, cells harboring pEspRes and a compatible plasmid producing C.Esp1396I formed colonies of deep red color ([Figure 2](#F2){ref-type="fig"}B, top, plate sector 2) and robust primer extension product corresponding to P*esp1396ICR* transcript was detected ([Figure 2](#F2){ref-type="fig"}B, bottom, lane 2). Thus, C.Esp1396I is required for P*esp1396ICR* activity. Cells carrying P*esp1396IM*::*galK* fusion plasmid formed purple colonies on McConkey plates ([Figure 2](#F2){ref-type="fig"}C, top, plate sector 1) and robust primer extension product corresponding to a transcript initiated from the P*esp1396IM* start site as well as two positions immediately upstream and downstream of this point were observed ([Figure 2](#F2){ref-type="fig"}C, bottom, lane 1). In contrast, cells harboring pEspMet and a compatible plasmid producing C.Esp1396I formed white colonies ([Figure 2](#F2){ref-type="fig"}C, top, plate sector 2) and no primer extension product corresponding to P*esp1396IM* transcript could be detected ([Figure 2](#F2){ref-type="fig"}C, bottom, lane 2). We therefore conclude that C.Esp1396I represses transcription from P*esp1396IM*.

*In vitro* analysis of C.Esp1396I effects on transcription from Esp1396I promoters
----------------------------------------------------------------------------------

To determine the effect of C.Esp1396I on the formation of transcription-competent open complexes on P*esp1396ICR*, KMnO~4~ probing was performed. The addition of the RNAP σ^70^ holoenzyme alone did not lead to appearance of KMnO~4~-sensitive thymines in the −10 element of P*esp1396ICR* ([Figure 3](#F3){ref-type="fig"}A, lane 3). However, the addition of 8-fold excess (over DNA) of C.Esp1396I and RNAP led to the appearance of robust KMnO~4~-sensitivity of thymines in the −10 element of P*esp1396ICR* and around the transcription start point ([Figure 3](#F3){ref-type="fig"}A, lane 4). The results thus indicate that C.Esp1396I promotes open complex formation on P*esp1396ICR*. *In vitro* transcription experiments revealed very little transcription from P*esp1396ICR* in the absence of C.Esp1396I ([Figure 3](#F3){ref-type="fig"}B, lane 1). The addition of increasing concentrations of C.Esp1396I strongly stimulated transcription initially, while further increase in the amount of C.Esp1396I led to gradual decrease in transcription (the latter effect was not strongly pronounced). Figure 3.*In vitro* transcription from *esp1396I* promoters. (**A**) *Escherichia coli* RNAP σ^70^ holoenzyme (100 nM) was combined with DNA fragments containing 8 nM *Pesp1396ICR* (**A**--**C**) or *Pesp1396IM* (**D** and **E**) in the presence, where indicated, of C.Esp1396I, whose concentrations ranged 0 to 500 nM. In (D), a component indicated by red color was added to DNA first, following an incubation long enough to allow complex formation and subsequent addition of component indicated by black color. In (A and D), complexes were probed with KMnO~4~. On the left of these panels, the sequence of the relevant portion of each promoter is mapped on the A+G sequencing marker lane. In (B and E), a single-round transcription reaction was performed. In (C), abortive initiation reaction was performed using RNAP holoenzymes reconstituted with indicated σ factors. Reaction products were separated by denaturing gel electrophoreses and revealed using a Phosphorimager.

Recently, a structure of C.Esp1396I bound to a binding site located upstream of P*esp1396ICR* was determined in one of our laboratories ([@B19]). The structure revealed two C.Esp1396I dimers that interacted with each other through a contact between Glu25 of a dimer bound to the distal (with respect to P*esp1396ICR* transcription start site) and Arg35 of the dimer bound to the proximal site. Based on molecular modeling, it has been proposed that the dimer bound to the distal site can activate transcription through a protein--protein interaction between Glu25 and Arg588 of the RNAP σ^70^ subunit ([@B19]). To test this hypothesis, we prepared recombinant σ^70^ subunit containing an alanine at position 588, and tested the ability of RNAP containing such subunit to transcribe from P*esp1396ICR* in the presence or in the absence of C.Esp1396I. The results, presented in [Figure 3](#F3){ref-type="fig"}C, demonstrate that RNAP holoenzyme containing mutant σ^70^ did not respond to C.Esp1396I, confirming the idea that Arg588 is required for transcription activation by C.Esp1396I.

KMnO~4~ probing showed robust open complex formation on P*esp1396IM* in the presence of RNAP σ^70^ holoenzyme ([Figure 3](#F3){ref-type="fig"}D, lane 3). The addition of increasing concentrations of C.Esp1396I to preformed P*esp1396IM* open complexes caused only a slight decrease in KMnO~4~ sensitivity ([Figure 3](#F3){ref-type="fig"}D, lanes 7--9), indicating that C.Esp1396I is relatively ineffective in dislodging P*esp1396IM* open complexes. In contrast, bound C.Esp1396I effectively inhibited promoter complex formation in a concentration-dependent manner ([Figure 3](#F3){ref-type="fig"}D, lanes 4--6). We therefore conclude that RNAP open complex formation and C.Esp1396I binding to P*esp1396IM* are mutually exclusive. This conclusion is supported by the results of electrophoretic mobility shift (EMSA) experiments that revealed that RNAP is unable to bind to P*esp1396IM* DNA in the presence of bound C.Esp1396I (data not shown). Transcription assays also showed that C.Esp1396I abolished transcription from P*esp1396IM* when added before ([Figure 3](#F3){ref-type="fig"}E), but not after (data not shown) RNAP.

*In vitro* analysis of C.Esp1396I interaction with its binding sites
--------------------------------------------------------------------

Sedimentation equilibrium analytical ultracentrifugation (AUC) experiments were carried out to confirm the dimeric status of C.Esp1396I and to obtain the *K*~d~ for dimerisation ([Supplementary Figure 1](http://nar.oxfordjournals.org/cgi/content/full/gkp210/DC1)). An M~r~ of 17 920 Da was obtained, which compares well with the theoretical M~r~ of an C.Esp1396I dimer (18 450 Da). Analysis of the data with a monomer--dimer equilibrium model gave a dimerization constant (*K*~d~) of ∼0.6 μM, 4-fold lower than that observed for C.AhdI ([@B14]), indicating that the C.Esp1396I dimer is significantly more stable.

The nature of complexes formed at each *esp1396I* promoter was determined in sedimentation-velocity AUC experiments using hex-labeled 35-bp *esp1396I* DNA fragments containing C.Esp1396I binding sites ([Figure 4](#F4){ref-type="fig"}). With the P*esp1396ICR* fragment at a protein:DNA ratio of 4:1, a single species with sedimentation coefficient of 3.9 S predominated. Using the frictional ratio derived from the fit, a molecular weight of 60 kDa was obtained, corresponding to a tetrameric complex with two C.Esp1396I dimers bound to DNA ([Supplementary Table 1](http://nar.oxfordjournals.org/cgi/content/full/gkp210/DC1)). At a protein:DNA ratio of 2:1, both the free DNA (2.7 S) and the tetrameric complex (3.9 S) were observed but no C.Esp1396I dimer--DNA complexes were discernible, indicating the high cooperativity of binding to P*esp1396ICR*. In the case of the P*esp1396IM* fragment, which contained the two putative C.Esp1396I binding sites originally postulated ([@B8]), identical plots were observed for both 4:1 and 2:1 protein:DNA ratios, with a single species sedimenting at 3.3 S. The derived molecular weight (40 kDa) corresponds to one C.Esp1396I dimer bound to the DNA. Thus, only one of the two postulated C-protein binding sites is occupied at the methylase promoter, even in the presence of excess protein. Moreover, the higher affinity of C.Esp1396I for the P*esp1396IM* site, compared to P*esp1396ICR* sites, is evident since the former is fully bound at 2:1 protein/DNA ratio, whereas the latter remains only partially bound at a 4:1 ratio. Figure 4.Sedimentation velocity analysis of C.Esp1396I--DNA complexes. The c(S) distribution plots for the C.Esp1386I-DNA complexes with P*esp1396ICR* (**A**) and P*esp1396IM* (**B**) derived 35-bp DNA fragments are shown. Plots labeled blue, red and green, correspond to free DNA duplex, a 2:1 C.Esp1396I:DNA molar ratio, and a 4:1 C.Esp1396I:DNA molar ratio, respectively. In all cases, the final concentration of the hex-labeled DNA duplex was 5 μM.

DNase I footprinting of a P*esp1396ICR*-containing DNA fragment revealed little protection in the presence of 4-fold molar excess of C.Esp1396I monomers over DNA ([Figure 5](#F5){ref-type="fig"}A, lane 2). However, in the presence of 8-fold excess of C.Esp1396I, complete protection of both sets of inverted repeats as well as adjacent bases was observed ([Figure 5](#F5){ref-type="fig"}A, lane 3), indicating formation of a tetrameric complex ([@B19]). The addition of C.Esp1396I to the P*esp1396IM* fragment resulted in complete protection of the entire inverted repeat and partial protection extending 5--6 bp in both directions outside the repeat in the presence of both 4-fold and 8-fold molar excess of C.Esp1396I monomers over DNA ([Figure 5](#F5){ref-type="fig"}B, lanes 2 and 3). The result thus confirms that C.Esp1396I binds P*esp1396IM* as a dimer, in agreement with the AUC data, and identifies the location of the binding site at this promoter. Figure 5.Footprinting of C.Esp1396I complexes with *esp1396I* promoters. A 4-fold (lane 2) or 8-fold (lane 3) excess of C.Esp1396I was combined with P*esp1396ICR* (**A**) or P*esp1396IM* (**B**) end-labeled DNA fragments; complexes were allowed to form and were footprinted with DNase I. On the left of each panel, the sequences of each promoter are shown along with promoter elements (red) and symmetry-related features of C.Esp1396I binding sites. In (B), only imperfect tetranucleotide repeats from a predicted second set of inverted repeats (see Figure 1) are shown at the top of the figure.

To derive equilibrium binding constants of C.Esp1396I interactions with its binding sites, we performed solution-based fluorescence polarization assays. Fluorescence polarization does not involve steps that could potentially perturb the binding equilibria being measured (such as physical separation of free and bound species) and therefore allows true equilibrium determinations of macromolecular interactions ([@B29],[@B30]). Promoter fragments were labeled at the 5′-end with fluorescein and fluorescence polarization of DNA fragments was measured as a function of C.Esp1396I concentration ([Figure 6](#F6){ref-type="fig"}A). Equilibrium constants describing the binding of C.Esp1396I were obtained by nonlinear regression analysis and fitting the data to a model involving binding of a single dimer of C.Esp1396I to P*esp1396IM*-containing fragment and cooperative binding of two C.Esp1396I dimers to P*esp1396ICR*-containing fragment. While satisfactory fits of polarization data for both P*esp1396IM* and P*esp1396ICR* sites could be obtained using either of these models, only the specific models described above were considered since they were consistent with data described above. Also, the models were consistent with higher total fluorescence polarization changes observed with P*esp1396ICR* DNA indicating larger complexes formed with this DNA ([Figure 6](#F6){ref-type="fig"}A, compare panels on the left and on the right). Figure 6.Interaction of C. Esp1396I with *esp1396I* binding sites measured by fluorescence polarization. (**A**) DNA binding of C.Esp1396I analyzed by fluorescence polarization of fluorescein-labeled P*esp1396ICR* (left) and P*esp1396IM* (right) DNA fragments. Solid lines show best fits of the models to experimental data. The best fit parameters for P*esp1936*I*CR* were *K*~p~ = 322 nM, *K*~d~ = 6.9 nM and cooperativity 219. The best fit equilibrium constant for P*esp1936*IM DNA was *K* = 0.3 nM. (**B**) Left panel: binding of C.Esp1396I to labeled P*esp1396*I*CR* DNA in the absence (gray symbols) and presence (black symbols) of unlabeled P*esp1396IM* DNA. Right panel: binding of C.Esp1396I to labeled P*esp1396IM* DNA in the absence (gray symbols) and presence (black symbols) of unlabeled P*esp1396ICR* DNA. Both labeled and competing unlabeled DNA (when present) were at 50 nM. Dashed lines depict predicted simulated binding using equilibrium constants derived from the analysis of the data illustrated in (A).

Quantitative analysis was performed assuming that C.Esp1396I exhibits monomer--dimer equilibrium with a dissociation constant of 600 nM (as determined by AUC, above). With these assumptions, the affinity of C.Esp1396I for the single P*esp1396IM* binding site (*K*~d~ = 0.3 nM) was much higher then the affinity for either of the P*esp1396ICR* binding sites (*K*~d~\'s of 6.9 and 322 nM for the distal and proximal sites, respectively). The significantly weaker binding of C.Esp1396I to the proximal site (O~R~) compared to the distal site (O~L~) is in agreement with the results of EMSA experiments ([@B19]).

The weaker binding of C.Esp1396I dimers to P*esp1396ICR* was partially compensated by high positive cooperativity between the sites (∼200-fold enhancement of binding affinity to a given site when the other site is occupied with the protein). Nevertheless, the net outcome is that P*esp1396IM* is a better binder than P*esp1396ICR*. This is best illustrated by competition experiments designed to determine how C.Esp1396I partitions between the P*esp1396IM* and P*esp1396ICR* sites. To this end, fluorescence polarization assays were performed at conditions of competition between P*esp1396IM* and P*esp1396ICR* fragments. The results, presented in [Figure 6](#F6){ref-type="fig"}B, show that unlabeled P*esp1396IM* was an effective competitor of the binding C.Esp1396I to labeled P*esp1396ICR* (left panel), whereas unlabeled P*esp1396ICR* had no effect on the binding of C.Esp1396I to labeled P*esp1396IM* (right panel). We therefore conclude that given a choice, C.Esp1396I binds to P*esp1396IM* first, and only then occupies the P*esp1396ICR* binding sites.

Mutational analysis of C.Esp1396I binding sites
-----------------------------------------------

Structural analysis of a complex of two C.Esp1396I dimers bound to the 35 bp P*esp1396ICR* site revealed, surprisingly, that the principal interactions that each dimer makes with its binding site are not determined by a pseudo 2-fold axis that separates two sets of inverted tetranucleotide repeats in the idealized consensus GACTnnnAGTCnnnGACTnnnAGTC ([@B19]). Rather, they are related by a 2-fold axis that is offset by half a base pair, which leads to a loss of a pseudo-dyad between the inverted tetranucleotide repeats but results in perfectly symmetrical TATA sequences located between each pair of repeats ([@B19]). In addition, TG and CA dinucleotides at the outside of the double site also become symmetrical with respect to this axis. In the structure, each C.Esp1396I dimer makes specific interactions with internal TATA spacers and outer TG/CA dinucleotides. The dyad axis of each dimer in the complex is located between the A and the T of the TATA spacer. For the purposes of the discussion presented below, it is convenient to use the notation introduced by McGeehan *et al.* ([@B19]), where C.Esp1396I subunits A/B comprise the dimer that binds the distal site, while the C/D dimer binds to the proximal site ([Figure 1](#F1){ref-type="fig"}). It is also important to note that in the crystal structure, the Arg35 side-chains of the central subunits B and C each appear in dual conformations (occupancy = 0.5) so that they can interact both with the DNA bases in the centre of the sequence, and with the Glu25 side-chains of adjacent subunits.

Analysis of the esp1396ICR promoter
-----------------------------------

To investigate further the interactions that contribute to site recognition by C.Esp1396I, EMSA experiments were performed with double-stranded DNA fragments carrying mutations in a 33 bp P*esp1396ICR* fragment containing both C.Esp1396I binding sites. We specifically sought to determine the importance of 'outer' dinucleotides TG and CA in positions 1, 2 and 32, 33, respectively, and what the consequences would be of introducing the 'missing' internal symmetry-related dinucleotide on C.Esp1396I binding to each site. Based on structural analysis, we expected that the former substitutions would decrease the binding, while introduction of symmetry related dinucleotides between the individual binding sites would increase the binding of a C.Esp1396I dimer to a site, while decreasing the cooperativity of the binding. We also introduced double substitutions in the tetranucleotide repeats, to check their importance for the binding, despite the apparent lack of visible specific interaction and the fact that these repeats are not symmetry related in the complex. The results are presented in [Figure 7](#F7){ref-type="fig"}A. For the wild-type fragment, a shifted band corresponding to a bound C.Esp1396I tetramer was observed, in agreement with the analyses above. A minor band corresponding to a dimer was seen only transiently at low concentrations of C.Esp1396I. Figure 7.Analysis of C.Esp1396I complexes with wild-type and mutant *esp1396I* promoters using electrophoretic mobility shift assay. (**A**) The sequences of the wild-type *esp1396ICR* C-boxes with symmetrical elements highlighted is presented at the top of the figure. Numbers below refer to positions of nucleotides in the C-box. The gels below show the results of native gel separation of complexes formed in the absence or in the presence of increasing concentrations of C.Esp1396I using wild-type *esp1396ICR* and various mutants. Note on nomenclature, every mutant fragment ('mut') is labeled to indicate positions of the boxes substituted (i.e. 1,2 in the second gel) and the bases introduced by the mutations (GT in the second gel). (**B**) As in (A), but using wild-type or mutant *esp1396IM* DNA fragments.

Substitution of the symmetry-related TG dinucleotide for GT at positions 1, 2 strongly decreased the amounts of complexes formed; however, all complexes detected corresponded to the tetrameric complex, i.e. two C.Esp1396I dimers bound to DNA. The observed decrease in binding efficiency is consistent with the significance of the TG dinucleotide for C.Esp1396I binding. Substitution of the symmetry-related CA dinucleotide for AC at positions 32, 33 abolished formation of the tetrameric complex; instead, a dimeric complex was formed. We attribute this to the fact that the proximal site is intrinsically weak ([@B19]) and that further reduction in binding affinity by substitution of the CA dinucleotide leads to binding only at the distal site.

A fragment containing a CA dinucleotide at positions 17 and 18 (symmetry related to the TG dinucleotide at positions 1, 2) did not form a low-mobility (tetrameric) complex, instead forming a dimeric complex. We suggest the following explanation. Introduction of the CA dinucleotide should favor the interaction of Arg35 of subunit B with these bases, rather than with Glu25 of subunit C in the adjacent dimer. As a result, cooperativity (i.e. enhancement of the binding of the second dimer to the proximal site) is reduced, leading to the occupation of the distal site only.

A fragment containing a TG dinucleotide at positions 16 and 17 (symmetry related to CA at positions 32, 33) did not form specific complexes with C.Esp1396I. Detailed examination of the structure of the complex provides a possible explanation for the absence of binding to the mutant DNA fragment. Although this mutation might be expected to enhance binding of the proximal dimer through the interaction of Arg35 of subunit C with the newly introduced TG, at the same time it would eliminate the possible interaction of Arg35 of subunit B with the highly conserved central GT, and thus weaken the binding of the A/B dimer to the distal site. Since a protein dimer has to bind to the distal site before occupying the proximal site, almost no DNA binding is observed.

For a fragment carrying a substitution in the tetranucleotide repeat in the distal site (positions 5, 6), only a band whose mobility corresponded to the expected mobility of a complex containing a single C.Esp1396I dimer was observed. For a fragment carrying a substitution in the tetranucleotide repeat in the proximal site (positions 27, 28), we observe a minor tetrameric complex band, together with a large diffuse band of higher mobility than that of the dimeric complex. A fragment carrying substitutions in tetranucleotide repeats in both C.Esp1396I binding sites did not form complexes with C.Esp1396I. Thus, the sequence of tetranucleotide repeats clearly contributes to DNA binding affinity. Further understanding of the precise interactions at these sites will require higher resolution structural data than those currently available.

Analysis of the esp1396IM promoter
----------------------------------

The sequence of the single C.Esp1396I binding site within P*esp1396IM* is more symmetrical than either of the two P*esp1396ICR* binding sites, with only two base pairs (positions 4 and 15) not conforming to palindromic symmetry around the dyad axis located within the central TATA sequence. The symmetrical base pairs include the outer TG/CA dinucleotides that are seen to interact strongly with Arg35 in the crystal structure of the tetrameric complex. The importance of the TATA-centered symmetry could explain the strong preference of C.Esp1396I for the M binding site compared to either the distal or proximal CR binding sites. To test this idea, we separately mutated the TG dinucleotide in positions 1, 2 and the equivalent CA dinucleotide in positions 17 and 18 of the P*esp1396IM* binding site. It was confirmed that these outer dinucleotides make a major contribution to DNA sequence recognition, as in both cases the binding was abolished ([Figure 7](#F7){ref-type="fig"}B).

Mutation of the central TATA (positions 10, 11) gave an unexpected result: although binding was significantly weakened, the mobility of the complex was lower than that for the wild type sequence. This probably represents a conformational change, as there is only one binding site on this 18-bp sequence. Since DNA bending results in enhanced gel mobility of C-protein complexes ([@B19],[@B31]), one plausible explanation of this result would be that changing TATA to TAGT disrupts the alternating purine--pyrimidine sequence and thus reduces DNA bending in the complex, giving rise to a lower mobility complex.

Next, we mutated two base pairs (positions 6 and 7) within the GAC/GTC sequence that are also related by symmetry around the TATA dyad (but were originally postulated to conform to the GACT/AGTC tetranucleotide repeat). This mutation completely abolishes DNA binding ([Figure 7](#F7){ref-type="fig"}B), showing that recognition of these sequences is also important.

Comparing the sequence of P*esp1396IM* with the previously proposed GACT. ... AGTC symmetry, Cesnaviciene *et al.* ([@B8]) suggested that this sequence aligned better to the consensus if an insertion was made in the "spacer" region. We therefore introduced an additional base (T) into the spacer region to see if DNA binding was enhanced. On the contrary, however, DNA binding to the mutant fragment (labeled 'wt+T' on [Figure 7](#F7){ref-type="fig"}B) was weakened when the TATA symmetry was perturbed by this insertion ([Figure 7](#F7){ref-type="fig"}B), despite the presence of GACT/AGTC palindromes on either side of the TAT spacer in the mutated sequence.

DISCUSSION
==========

In this work, we map *Esp*1396I promoters and demonstrate that transcription of both the restriction endonuclease and methyltransferase genes is controlled by interdependent regulatory loops governed by the C.Esp1396I protein. In the absence of C.Esp1396I, i.e. in a situation encountered when the Esp1396I system genes enter a naïve host, the *esp1396IM* promoter is highly active, leading to production of the Esp1396I methyltransferase and methylation of Esp1396I sites in the host genome. Basal transcription from P*esp1396ICR* results in gradual accumulation of C.Esp1396I, which upon dimerization binds to a single site in P*esp1396IM*, preventing further transcription from this promoter. Further accumulation of C.Esp1396I results in activation and then gradual repression of P*esp1396ICR*. The interaction of C.Esp1396I with the binding sites in P*esp1396ICR* is highly cooperative and we were unable to detect an 'activating' complex of C.Esp1396I dimer with the distal binding site. Instead, a 'repressing' complex of C.Esp1396I tetramer bound to both binding sites was detected. A similar situation was encountered during the analysis of *ahdICR* promoter regulation by C.AhdI ([@B17]). There, we showed that transcription activation by C.AhdI can be quantitatively explained by a model in which RNAP outcompetes the C.AhdI dimer from the promoter--proximal binding site due to favorable interactions between the C.AhdI dimer bound at promoter--distal site (O~L~) and RNAP. The same mechanism of transcription activation is likely operational in the case of P*esp1396ICR*. *In vitro*, such mechanism of activation is quite inefficient, since only a small fraction of templates becomes transcriptionally active even when transcription reaches its maximal levels. Indeed, even at conditions when maximal amounts of open promoter complexes at P*esp1396ICR* were formed *in vitro* (as judged by KMnO~4~ probing) no DNase I footprint of RNAP could be detected (data not shown). The apparent inefficiency of C.Esp1396I activation is likely to be biologically significant as it decreases the steady-state level of expression of restriction endonuclease, a highly toxic protein. This represents a 'trade-off' between optimizing the efficiency of transcription of the endonuclease gene, and ensuring complete shut-down of the gene once sufficient enzyme has been synthesized, the latter being more critical.

Unlike most other R-M systems studied, unregulated expression of Esp1396I methylase from its own promoter is toxic to the cell. The effect must be unrelated to specific methylation activity of the enzyme, since all recognition sites in the host genome must be methylated to prevent restriction. The preferential binding of C.Esp1396I to the P*esp1396IM* site decreases the level of *esp1396IM* expression even before P*esp1396ICR* is fully turned on. Presumably evolution has fine-tuned the binding affinities of the operators (and in the case of the C/R promoter, the protein-protein interactions responsible for cooperativity) to optimize the time-dependence and steady-state activity of both methylation and restriction in a coordinated manner. Bioinformatic analysis reveals that several other C-protein dependent systems are organized similarly to Esp1396I (8, V. Sorokin, M. Gelfand, and K.S., unpublished data). In all cases, palindromic sites that likely function as C-protein binding sites are present in front of both the M and CR genes.

The relative binding affinities of C.Esp1396I for the three operator sites involved in this regulatory control circuit are markedly different, reflecting their differing biological functions. The highest affinity binding site for C.Esp1396I is the operator site O~M~ controlling repression of the methyltransferase, the binding affinity of which is ∼20-fold higher than that of the distal operator (O~L~) that activates transcription of the C/R promoter. The distal operator in turn has ∼50-fold higher affinity than the proximal binding site (O~R~) that governs repression of the C and R genes. Nevertheless, the O~R~ site is occupied soon after the O~L~ site, due to the high degree of cooperativity (∼200) that arises, at least in part, from the interaction of Arg35 and Glu25 at the interface of adjacent dimers ([@B19]). This solution (rather than having a high intrinsic affinity for O~R~) ensures that transcription of the C/R genes occurs at low levels of controller protein, whilst still allowing complete repression at higher concentrations of the protein.

All three operators ([Figure 8](#F8){ref-type="fig"}) have in common the central TATA sequence that allows compression of the minor groove of the DNA, forcing DNA bending at the centre of the dimer binding site in the complex ([@B19]). The strongest binding site, O~M~, in addition contains the symmetry related TG and CA dinucleotide sequences that interact strongly with Arg35 of the controller protein ([@B19]), whereas O~L~ and O~R~ have just one of these dinucleotides (clearly, both TG and CA are not possible simultaneously as the binding sites overlap in this region). It is notable that the sequence of the highest affinity site, O~M~, is almost perfectly palindromic, with 16 of the 18 bases being related by dyad symmetry ([Figure 8](#F8){ref-type="fig"}). Indeed, at least two of the three operators have identical bases at these 16 sites, of which 7 consecutive bases (TATAGTC) are identical in all three operators. Figure 8.Comparison of operator sequences in Esp1396I. C.Esp1396I binding sites at the CR promoter (proximal, O~R~; distal, O~L~) and the M promoter (O~M~) are aligned. Indicated in yellow are the sites where at least 2/3 of the sequences are identical, seven of which (red lettering) are found in all three. A symmetrical consensus sequence is shown below, closely matching the O~M~ site. Bases identified from the crystal structure as being involved in DNA--protein interactions are indicated in blue; other symmetrical bases likely to interact with helix 3 of the protein are shown in magenta.

Our mutational studies show the importance of the interactions with the TATA and TG/CA bases for complex formation, in agreement with the protein--DNA interactions seen in the crystal structure of the complex ([@B19]). In addition, however, it is clear that mutations within the so-called 'tetranucleotide repeats' also diminish binding of C.Esp1396I, as has also recently been shown for C.PvuII ([@B32]). Interactions of amino acids with bases in this region cannot be clearly identified in the crystal structure at this resolution, but are likely to be present, since this is where the recognition helix (helix 3) inserts into the major groove. Nevertheless, we have shown that insertion of an additional base into the TATA sequence to make the GACT/AGCT sequences symmetric around a TAT spacer reduces DNA binding. Clearly the DNA sequence and structure recognition mechanisms of controller proteins are yet to be fully understood. High-resolution crystallographic studies with all three operator sites are in progress to identify the precise intermolecular interactions in each case.
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